ASGCT Position Statement: Addressing the Value of Gene Therapy and Enhancing Patient Access to Transformative Treatments

Molecular Therapy - United States
doi 10.1016/j.ymthe.2018.10.017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Correction To: ACMT Position Statement: Addressing the Rising Cost of Prescription Antidotes

Journal of Medical Toxicology
MutagenesisToxicologyHealth
2018English

Ensuring Center Quality, Proper Patient Selection and Fair Access to Chimeric Antigen Receptor T-Cell Therapy: Position Statement of the Austrian CAR-T Cell Network

Memo - Magazine of European Medical Oncology
OncologyHematology
2020English

Equitable Access to Gene Therapy: A Call to Action for the American Society of Gene and Cell Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2018English

Electroconvulsive Therapy Use Among Depressive Inpatients : Position Statement

Middle East Journal of Nursing
2016English

EMAS Position Statement: Testosterone Replacement Therapy in the Aging Male‏

Maturitas
BiochemistryGynecologyGeneticsObstetricsMolecular Biology
2016English

Spinal Motion Restriction in the Trauma Patient – A Joint Position Statement

Prehospital Emergency Care
Emergency NursingEmergency Medicine
2018English

Pnd105 - Multiple Sclerosis: The Map of Patient Access to Disease Modifying Treatments in Europe

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Harmonizing Core Platforms in the Delivery of Patient-Specific Cell Therapies to Accelerate Patient Access to Life-Changing Treatments

American Journal of Biomedical Science & Research
2019English

Global Consensus Position Statement on the Use of Testosterone Therapy for Women

Maturitas
BiochemistryGynecologyGeneticsObstetricsMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy